News Details

MONTREAL--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform in the United States, is now serving customers in Canada. This entry follows the recent acquisition of Livewell, a trusted Canadian digital health platform focused on weight loss. Through this expansion, Hims & Hers is well-positioned to usher in the next era of digital health to Canada, bringing its established commitment to providing access to affordable, personalized, and customer-first care.

Building on a strong foundation in both the US and Europe, the entry into Canada positions Hims & Hers to lead the next era of digital health, centered on providing access to customer-first, affordable, and personalized care.

This investment in Canada will help accelerate an improved, more accessible, and affordable future for individuals seeking weight management treatment. Currently, effective treatment options remain out of reach for many of the two-thirds of Canadian adults who are overweight or living with obesity. This expansion is expected to help accelerate the launch of Hims & Hers’ accessible, comprehensive weight loss program in Canada next year, timed to align with the first anticipated availability of generic semaglutide anywhere in the world. Hims & Hers’ innovative digital platform will help millions of Canadians have access to personalized, high-quality care.

To best serve its new Canadian customers, Hims & Hers is establishing dedicated local leadership and deep medical expertise. Canadian business leader Austin Kouri will take the helm in-market as the General Manager of Canada, working closely with Hims & Hers’ advisor and new Chief Medical Officer in Canada, Dr. Sandy Van, MD, CCFP, ABOM Dipl, a leading Obesity Physician. Livewell co-founders Antoine Arbour and Patrick Duffy will also be joining Hims & Hers’ Canadian leadership team. This country-first team underscores the company’s commitment to localized leadership, understanding, and specialized medical expertise.

"Our expansion into Canada is a direct response to critical public health needs, particularly around the obesity crisis," said Andrew Dudum, co-founder and CEO of Hims & Hers. "This serves as a fundamental next step in delivering on our core promise: to democratize access to personalized, high-quality care. We are charting a path toward bringing the trusted Hims & Hers experience to more and more global markets over the coming years."

“Bringing Hims & Hers to Canada is a powerful investment in the health and wellness of Canadians,” said Austin Kouri, GM of Canada at Hims & Hers. “Our digital platform can complement the health system, providing access to specialized, timely, and affordable care, especially for prevalent, persistent conditions like obesity. Our goal is clear: to ensure every Canadian can easily access the care they need to help live a healthier, more fulfilling life.”

"The demand for effective and easy-to-access obesity care is continuing to grow in Canada," said Antoine Arbour, co-founder of Livewell. "Joining Hims & Hers represents a vital step forward, allowing us to be a part of the global movement to democratize access to essential care. By combining our expertise, we can begin building the foundation to reach millions of Canadians nationwide."

Hims & Hers expects to continue expanding into more specialties in Canada as demand for access to personalized healthcare continues to grow.

About Hims & Hers Health, Inc

Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health. We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the company provides access to personalized care designed for results. For more information, please visit www.hims.com and www.forhers.com.

About Livewell

Livewell is a trusted Canadian digital health platform focused on weight loss treatment. With licensed providers supporting customers throughout Canada, Livewell delivers access to safe, personalized, and affordable treatment plans through a digital-first platform. Livewell’s nationwide reach and commitment to long-term support are helping transform how Canadians access weight loss treatment.

Cautionary Note Regarding Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “assume,” “may,” “will,” “likely,” “potential,” “projects,” “predicts,” “continue,” “goal,” “strategy,” “future,” “forecast,” “target,” “outlook,” “opportunity,” “project,” “confidence,” “foundation,” “groundwork,” or “should,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, statements regarding Hims & Hers’ continued expansion into Canada, the anticipated benefits of the acquisition of Livewell, the expected timing of new products or offerings, and assumptions relating to the foregoing. These statements are based on management’s current expectations, but actual results may differ materially due to various factors.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, the forward-looking statements contained in this press release are based on our current expectations, assumptions and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, uncertainties relating to the integration of Livewell; our ability to successfully expand into new markets or specialties; our ability to launch new programs or product offerings on expected timelines or at all; changes in healthcare, consumer protection or privacy laws; increased scrutiny from regulators; the impact of general economic, business, or financial conditions; and other factors described in the Risk Factors and other sections of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and other current and periodic reports we file from time to time with the Securities and Exchange Commission.

Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. The forward-looking statements contained in this press release are made only as of December 4, 2025. We undertake no obligation (and expressly disclaim any obligation) to update or revise any forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from those made in or suggested by the forward-looking statements contained in this press release.